Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boris Duchemann

Showing results (61-70 of 83) with videos related to

Pageof 9
Sort By:
Cancer Immunology Research|July 2, 2025
Regulatory T cells poise the myeloid landscape after chemotherapy in lung tumorsEléonore Weber-Delacroix, Marylou Panouillot, Marie Laviron, et al.
Lung Cancer (Amsterdam, Netherlands)|October 3, 2025
Real-world efficacy and safety of amivantamab in EGFR exon-20-mutant non-small cell lung cancer in a French early-access program: Amexon 20 GFPC studyThomas Pierret, Laurent Greillier, Florian Guisier, et al.
Infectious Diseases (London, England)|May 24, 2021
A short course of corticosteroids reduces the risk of mechanical ventilation and death in patients with moderate to severe COVID 19 pneumonia: results of a retrospective monocentric cohortCeline Comparon, Marouane Boubaya, Nanthara Sritharan, et al.
Frontiers in Oncology|July 17, 2023
Radiation-induced lung injury after breast cancer treatment: incidence in the CANTO-RT cohort and associated clinical and dosimetric risk factorsAnna Gueiderikh, Thomas Sarrade, Youlia Kirova, et al.
Ebiomedicine|February 21, 2025
Overall survival according to time-of-day of combined immuno-chemotherapy for advanced non-small cell lung cancer: a bicentric bicontinental studyZhe Huang, Abdoulaye Karaboué, Liang Zeng, et al.
Science Advances|November 8, 2023
Human virome profiling identified CMV as the major viral driver of a high accumulation of senescent CD8<sup>+</sup> T cells in patients with advanced NSCLCMarie Naigeon, Matthieu Roulleaux Dugage, François-Xavier Danlos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2020
Circulating T-cell Immunosenescence in Patients with Advanced Non-small Cell Lung Cancer Treated with Single-agent PD-1/PD-L1 Inhibitors or Platinum-based ChemotherapyRoberto Ferrara, Marie Naigeon, Edouard Auclin, et al.
JAMA Surgery|May 28, 2025
Tracheobronchial Replacement: A Systematic ReviewEmmanuel Martinod, Dana M Radu, Ilaria Onorati, et al.
JTCVS Techniques|October 19, 2023
Preliminary results in tracheal replacement using stented aortic matrices for primary extensive tracheal cancerIlaria Onorati, Dana M Radu, Ana Maria Santos Portela, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 20, 2019
Outcome of Patients with Non-Small Cell Lung Cancer and Brain Metastases Treated with Checkpoint InhibitorsLizza E L Hendriks, Clemence Henon, Edouard Auclin, et al.
Pageof 9

Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
Cancer Immunology Research|July 2, 2025
Regulatory T cells poise the myeloid landscape after chemotherapy in lung tumorsEléonore Weber-Delacroix, Marylou Panouillot, Marie Laviron, et al.
Lung Cancer (Amsterdam, Netherlands)|October 3, 2025
Real-world efficacy and safety of amivantamab in EGFR exon-20-mutant non-small cell lung cancer in a French early-access program: Amexon 20 GFPC studyThomas Pierret, Laurent Greillier, Florian Guisier, et al.
Infectious Diseases (London, England)|May 24, 2021
A short course of corticosteroids reduces the risk of mechanical ventilation and death in patients with moderate to severe COVID 19 pneumonia: results of a retrospective monocentric cohortCeline Comparon, Marouane Boubaya, Nanthara Sritharan, et al.
Frontiers in Oncology|July 17, 2023
Radiation-induced lung injury after breast cancer treatment: incidence in the CANTO-RT cohort and associated clinical and dosimetric risk factorsAnna Gueiderikh, Thomas Sarrade, Youlia Kirova, et al.
Ebiomedicine|February 21, 2025
Overall survival according to time-of-day of combined immuno-chemotherapy for advanced non-small cell lung cancer: a bicentric bicontinental studyZhe Huang, Abdoulaye Karaboué, Liang Zeng, et al.
Science Advances|November 8, 2023
Human virome profiling identified CMV as the major viral driver of a high accumulation of senescent CD8<sup>+</sup> T cells in patients with advanced NSCLCMarie Naigeon, Matthieu Roulleaux Dugage, François-Xavier Danlos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2020
Circulating T-cell Immunosenescence in Patients with Advanced Non-small Cell Lung Cancer Treated with Single-agent PD-1/PD-L1 Inhibitors or Platinum-based ChemotherapyRoberto Ferrara, Marie Naigeon, Edouard Auclin, et al.
JAMA Surgery|May 28, 2025
Tracheobronchial Replacement: A Systematic ReviewEmmanuel Martinod, Dana M Radu, Ilaria Onorati, et al.
JTCVS Techniques|October 19, 2023
Preliminary results in tracheal replacement using stented aortic matrices for primary extensive tracheal cancerIlaria Onorati, Dana M Radu, Ana Maria Santos Portela, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 20, 2019
Outcome of Patients with Non-Small Cell Lung Cancer and Brain Metastases Treated with Checkpoint InhibitorsLizza E L Hendriks, Clemence Henon, Edouard Auclin, et al.
Pageof 9